

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.91782523 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 6.38447703 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.38447703 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.38447703 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.38447703 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 6.38447703 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 6.38447703 |
| 8 | microglial cell activation (GO:0001774) | 5.97184886 |
| 9 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.42784176 |
| 10 | macrophage activation involved in immune response (GO:0002281) | 5.15882822 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 4.81480569 |
| 12 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.31052979 |
| 13 | negative regulation of cell killing (GO:0031342) | 4.30465135 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.30465135 |
| 15 | positive regulation of interferon-alpha production (GO:0032727) | 4.29715185 |
| 16 | interferon-gamma production (GO:0032609) | 4.28564253 |
| 17 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.26084794 |
| 18 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.25493695 |
| 19 | macrophage activation (GO:0042116) | 4.18363662 |
| 20 | response to host immune response (GO:0052572) | 4.11847284 |
| 21 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.11847284 |
| 22 | regulation of interferon-alpha production (GO:0032647) | 4.07551822 |
| 23 | cellular extravasation (GO:0045123) | 4.05569878 |
| 24 | respiratory burst (GO:0045730) | 4.00611583 |
| 25 | positive regulation of chemokine secretion (GO:0090197) | 3.97865407 |
| 26 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.95159185 |
| 27 | myeloid cell activation involved in immune response (GO:0002275) | 3.94931248 |
| 28 | response to peptidoglycan (GO:0032494) | 3.94153000 |
| 29 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.91567870 |
| 30 | regulation of chronic inflammatory response (GO:0002676) | 3.91098092 |
| 31 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.80499817 |
| 32 | immunoglobulin mediated immune response (GO:0016064) | 3.79039469 |
| 33 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.78961817 |
| 34 | response to host (GO:0075136) | 3.78961817 |
| 35 | response to host defenses (GO:0052200) | 3.78961817 |
| 36 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.74852773 |
| 37 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.73552986 |
| 38 | regulation of T cell tolerance induction (GO:0002664) | 3.72356016 |
| 39 | granulocyte activation (GO:0036230) | 3.69012240 |
| 40 | T-helper 1 type immune response (GO:0042088) | 3.64701096 |
| 41 | neutrophil activation (GO:0042119) | 3.62651484 |
| 42 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.61756662 |
| 43 | T cell migration (GO:0072678) | 3.61423813 |
| 44 | positive regulation of antigen processing and presentation (GO:0002579) | 3.58526933 |
| 45 | NIK/NF-kappaB signaling (GO:0038061) | 3.57275246 |
| 46 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.55891190 |
| 47 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.54274036 |
| 48 | positive regulation of type 2 immune response (GO:0002830) | 3.51945140 |
| 49 | regulation of podosome assembly (GO:0071801) | 3.50226788 |
| 50 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.44902893 |
| 51 | activated T cell proliferation (GO:0050798) | 3.43867457 |
| 52 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.40633869 |
| 53 | glycosphingolipid catabolic process (GO:0046479) | 3.36954682 |
| 54 | regulation of vitamin metabolic process (GO:0030656) | 3.35657316 |
| 55 | * cellular defense response (GO:0006968) | 3.32726152 |
| 56 | regulation of mononuclear cell migration (GO:0071675) | 3.31608120 |
| 57 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.30955517 |
| 58 | positive regulation of mast cell activation (GO:0033005) | 3.30287493 |
| 59 | germinal center formation (GO:0002467) | 3.28498545 |
| 60 | regulation of gamma-delta T cell activation (GO:0046643) | 3.28336960 |
| 61 | regulation of tolerance induction (GO:0002643) | 3.28237259 |
| 62 | regulation of mast cell degranulation (GO:0043304) | 3.25744433 |
| 63 | regulation of chemokine biosynthetic process (GO:0045073) | 3.24531628 |
| 64 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.23790927 |
| 65 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.21510895 |
| 66 | myeloid leukocyte activation (GO:0002274) | 3.20831586 |
| 67 | positive regulation of interferon-beta production (GO:0032728) | 3.18588061 |
| 68 | lymphocyte chemotaxis (GO:0048247) | 3.18400596 |
| 69 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.17918740 |
| 70 | regulation of monocyte chemotaxis (GO:0090025) | 3.17798554 |
| 71 | detection of other organism (GO:0098543) | 3.17594328 |
| 72 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.16714741 |
| 73 | regulation of interleukin-12 production (GO:0032655) | 3.16369963 |
| 74 | cellular response to interleukin-15 (GO:0071350) | 3.16218839 |
| 75 | detection of molecule of bacterial origin (GO:0032490) | 3.15972112 |
| 76 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.15444223 |
| 77 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.15086070 |
| 78 | regulation of mast cell activation (GO:0033003) | 3.12352418 |
| 79 | regulation of antigen processing and presentation (GO:0002577) | 3.11786847 |
| 80 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.11128402 |
| 81 | positive regulation of heat generation (GO:0031652) | 3.09546318 |
| 82 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.08056088 |
| 83 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.07222516 |
| 84 | mast cell activation (GO:0045576) | 3.07005306 |
| 85 | response to muramyl dipeptide (GO:0032495) | 3.05610979 |
| 86 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.05574849 |
| 87 | negative regulation of granulocyte differentiation (GO:0030853) | 3.05363848 |
| 88 | positive regulation of lymphocyte migration (GO:2000403) | 3.05291452 |
| 89 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.03241689 |
| 90 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.02863673 |
| 91 | positive regulation of mast cell degranulation (GO:0043306) | 3.02863673 |
| 92 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.02380159 |
| 93 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.02293594 |
| 94 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.02213280 |
| 95 | defense response to protozoan (GO:0042832) | 3.01952020 |
| 96 | regulation of type 2 immune response (GO:0002828) | 3.01549653 |
| 97 | glycolipid catabolic process (GO:0019377) | 3.01381374 |
| 98 | negative regulation of interleukin-17 production (GO:0032700) | 3.01334070 |
| 99 | I-kappaB phosphorylation (GO:0007252) | 3.00849412 |
| 100 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.00574332 |
| 101 | positive regulation of T cell migration (GO:2000406) | 2.99801487 |
| 102 | myeloid dendritic cell activation (GO:0001773) | 2.99338246 |
| 103 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.99140626 |
| 104 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.97979984 |
| 105 | positive regulation of tolerance induction (GO:0002645) | 2.97807527 |
| 106 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.97701710 |
| 107 | cellular response to interferon-beta (GO:0035458) | 2.97223990 |
| 108 | cellular response to interferon-gamma (GO:0071346) | 2.96774985 |
| 109 | positive regulation of B cell differentiation (GO:0045579) | 2.96360004 |
| 110 | negative regulation of interleukin-12 production (GO:0032695) | 2.96022315 |
| 111 | regulation of fever generation (GO:0031620) | 2.96013017 |
| 112 | B cell mediated immunity (GO:0019724) | 2.95815842 |
| 113 | regulation of chemokine secretion (GO:0090196) | 2.95450725 |
| 114 | tolerance induction (GO:0002507) | 2.95112473 |
| 115 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.93971448 |
| 116 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.92961135 |
| 117 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.92961135 |
| 118 | myeloid dendritic cell differentiation (GO:0043011) | 2.89973138 |
| 119 | type I interferon signaling pathway (GO:0060337) | 2.89034944 |
| 120 | cellular response to type I interferon (GO:0071357) | 2.89034944 |
| 121 | detection of bacterium (GO:0016045) | 2.88798552 |
| 122 | negative regulation of T cell mediated immunity (GO:0002710) | 2.87574925 |
| 123 | response to type I interferon (GO:0034340) | 2.87291994 |
| 124 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.86593424 |
| 125 | dendritic cell differentiation (GO:0097028) | 2.86498452 |
| 126 | regulation of lymphocyte migration (GO:2000401) | 2.85766500 |
| 127 | detection of external biotic stimulus (GO:0098581) | 2.85602790 |
| 128 | B cell receptor signaling pathway (GO:0050853) | 2.85097435 |
| 129 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.84890189 |
| 130 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.84808126 |
| 131 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.84755718 |
| 132 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.84389480 |
| 133 | positive regulation of interferon-gamma production (GO:0032729) | 2.84019819 |
| 134 | response to interferon-gamma (GO:0034341) | 2.81958600 |
| 135 | oligosaccharide catabolic process (GO:0009313) | 2.81848354 |
| 136 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.80398518 |
| 137 | response to interleukin-15 (GO:0070672) | 2.79620838 |
| 138 | regulation of macrophage chemotaxis (GO:0010758) | 2.79436093 |
| 139 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.79241487 |
| 140 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.78564670 |
| 141 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.78418155 |
| 142 | positive regulation of T cell chemotaxis (GO:0010820) | 2.78170829 |
| 143 | regulation of T cell chemotaxis (GO:0010819) | 2.78170829 |
| 144 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.77778521 |
| 145 | response to protozoan (GO:0001562) | 2.77245210 |
| 146 | positive regulation of interleukin-12 production (GO:0032735) | 2.76512751 |
| 147 | monocyte chemotaxis (GO:0002548) | 2.76329450 |
| 148 | natural killer cell activation (GO:0030101) | 2.75839701 |
| 149 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.75648105 |
| 150 | neutrophil chemotaxis (GO:0030593) | 2.75351174 |
| 151 | * cellular response to lipopolysaccharide (GO:0071222) | 2.75170656 |
| 152 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.75073821 |
| 153 | amino sugar catabolic process (GO:0046348) | 2.73793564 |
| 154 | * cellular response to molecule of bacterial origin (GO:0071219) | 2.71280624 |
| 155 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.70467615 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.59866552 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.58658206 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.20496780 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.88671656 |
| 5 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.79972184 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.32319893 |
| 7 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.71812456 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.56425058 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.54525245 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.47340792 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.37868206 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.23875636 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.93651545 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.70835636 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.64037561 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.41231909 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.41123634 |
| 18 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.17221875 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.11187211 |
| 20 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.09051083 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.05459798 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.04219817 |
| 23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.01410246 |
| 24 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.00439011 |
| 25 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.98247692 |
| 26 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.97795920 |
| 27 | * MYB_26560356_Chip-Seq_TH2_Human | 1.89871723 |
| 28 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.89396399 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.88614399 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.82323825 |
| 31 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.80560358 |
| 32 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.76567578 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.74256959 |
| 34 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.65513245 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64688988 |
| 36 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.55005664 |
| 37 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52674591 |
| 38 | MYB_26560356_Chip-Seq_TH1_Human | 1.49569625 |
| 39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.45791151 |
| 40 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45128500 |
| 41 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.44684248 |
| 42 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.39927802 |
| 43 | MAF_26560356_Chip-Seq_TH1_Human | 1.38308623 |
| 44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30132799 |
| 45 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.28631850 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.28116653 |
| 47 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27241658 |
| 48 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.27032148 |
| 49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24352871 |
| 50 | GATA3_26560356_Chip-Seq_TH2_Human | 1.23902727 |
| 51 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22279475 |
| 52 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.21527226 |
| 53 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20006985 |
| 54 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.19844537 |
| 55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19329889 |
| 56 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.18913607 |
| 57 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18883746 |
| 58 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.16948699 |
| 59 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.16210127 |
| 60 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14910643 |
| 61 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.12896632 |
| 62 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.11893382 |
| 63 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.11145128 |
| 64 | MYC_22102868_ChIP-Seq_BL_Human | 1.09729844 |
| 65 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07852380 |
| 66 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.06391050 |
| 67 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05425912 |
| 68 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04645630 |
| 69 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.04370330 |
| 70 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.04118351 |
| 71 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02683759 |
| 72 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.00052880 |
| 73 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.98371941 |
| 74 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98095375 |
| 75 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95948022 |
| 76 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.94795054 |
| 77 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.94694914 |
| 78 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94553504 |
| 79 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93958882 |
| 80 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.93309182 |
| 81 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.91991285 |
| 82 | UTX_26944678_Chip-Seq_JUKART_Human | 0.90978974 |
| 83 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.90465111 |
| 84 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89683242 |
| 85 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.89549877 |
| 86 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.88905455 |
| 87 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88505992 |
| 88 | CJUN_26792858_Chip-Seq_BT549_Human | 0.87005592 |
| 89 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83278930 |
| 90 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82836352 |
| 91 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.82121592 |
| 92 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.81092346 |
| 93 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.80846909 |
| 94 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.79799437 |
| 95 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.79035916 |
| 96 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.78889755 |
| 97 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.78432469 |
| 98 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.77549403 |
| 99 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.77368557 |
| 100 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.77368557 |
| 101 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.77198036 |
| 102 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.76656256 |
| 103 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76497035 |
| 104 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74982993 |
| 105 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.74781231 |
| 106 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.74299361 |
| 107 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72213293 |
| 108 | TP53_16413492_ChIP-PET_HCT116_Human | 0.70761033 |
| 109 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.70369266 |
| 110 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.68847903 |
| 111 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.68785184 |
| 112 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.68411166 |
| 113 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.67949439 |
| 114 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.67402135 |
| 115 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.65860746 |
| 116 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.65684176 |
| 117 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.64799518 |
| 118 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.62608412 |
| 119 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.61630109 |
| 120 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.61280662 |
| 121 | MAF_26560356_Chip-Seq_TH2_Human | 0.60041244 |
| 122 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.58869830 |
| 123 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.58541043 |
| 124 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.56769697 |
| 125 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.56547539 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006082_CNS_inflammation | 5.32581269 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.57777638 |
| 3 | * MP0005671_abnormal_response_to | 3.99573303 |
| 4 | MP0003436_decreased_susceptibility_to | 3.41950509 |
| 5 | MP0005000_abnormal_immune_tolerance | 3.25050296 |
| 6 | * MP0002419_abnormal_innate_immunity | 3.22355822 |
| 7 | * MP0002148_abnormal_hypersensitivity_rea | 3.16464934 |
| 8 | MP0009785_altered_susceptibility_to | 3.10121042 |
| 9 | MP0003724_increased_susceptibility_to | 3.05358800 |
| 10 | MP0005058_abnormal_lysosome_morphology | 3.01663645 |
| 11 | MP0003303_peritoneal_inflammation | 2.92254674 |
| 12 | * MP0005025_abnormal_response_to | 2.91358647 |
| 13 | * MP0001800_abnormal_humoral_immune | 2.81038259 |
| 14 | * MP0002452_abnormal_antigen_presenting | 2.80735792 |
| 15 | MP0005387_immune_system_phenotype | 2.77330597 |
| 16 | MP0001790_abnormal_immune_system | 2.77330597 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.75123511 |
| 18 | * MP0002723_abnormal_immune_serum | 2.69840215 |
| 19 | * MP0001819_abnormal_immune_cell | 2.47410777 |
| 20 | * MP0002420_abnormal_adaptive_immunity | 2.45403397 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.40226789 |
| 22 | MP0003172_abnormal_lysosome_physiology | 2.34165623 |
| 23 | MP0003448_altered_tumor_morphology | 2.13508473 |
| 24 | MP0000685_abnormal_immune_system | 2.12393320 |
| 25 | MP0002139_abnormal_hepatobiliary_system | 2.10705076 |
| 26 | MP0001533_abnormal_skeleton_physiology | 2.10485455 |
| 27 | MP0003690_abnormal_glial_cell | 2.08306312 |
| 28 | MP0004510_myositis | 1.99821600 |
| 29 | MP0002405_respiratory_system_inflammati | 1.97531032 |
| 30 | MP0005451_abnormal_body_composition | 1.96798510 |
| 31 | * MP0001845_abnormal_inflammatory_respons | 1.85481273 |
| 32 | MP0001851_eye_inflammation | 1.76031175 |
| 33 | MP0003075_altered_response_to | 1.75954825 |
| 34 | MP0001853_heart_inflammation | 1.75495471 |
| 35 | * MP0000716_abnormal_immune_system | 1.73912056 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.72577209 |
| 37 | MP0005166_decreased_susceptibility_to | 1.71018774 |
| 38 | * MP0008469_abnormal_protein_level | 1.68790937 |
| 39 | MP0005310_abnormal_salivary_gland | 1.63804570 |
| 40 | * MP0002398_abnormal_bone_marrow | 1.59402168 |
| 41 | MP0002998_abnormal_bone_remodeling | 1.59201858 |
| 42 | MP0005167_abnormal_blood-brain_barrier | 1.54111293 |
| 43 | MP0003300_gastrointestinal_ulcer | 1.48764391 |
| 44 | MP0004947_skin_inflammation | 1.47554914 |
| 45 | MP0000689_abnormal_spleen_morphology | 1.46675089 |
| 46 | MP0002006_tumorigenesis | 1.44524963 |
| 47 | * MP0000343_altered_response_to | 1.41778283 |
| 48 | * MP0010155_abnormal_intestine_physiology | 1.41597110 |
| 49 | MP0003828_pulmonary_edema | 1.40081591 |
| 50 | * MP0002429_abnormal_blood_cell | 1.34916276 |
| 51 | MP0003806_abnormal_nucleotide_metabolis | 1.33212563 |
| 52 | MP0000920_abnormal_myelination | 1.32043728 |
| 53 | MP0002722_abnormal_immune_system | 1.31056428 |
| 54 | MP0006054_spinal_hemorrhage | 1.30376711 |
| 55 | MP0002166_altered_tumor_susceptibility | 1.29383122 |
| 56 | MP0009764_decreased_sensitivity_to | 1.28988860 |
| 57 | MP0002277_abnormal_respiratory_mucosa | 1.26771509 |
| 58 | MP0000858_altered_metastatic_potential | 1.25587096 |
| 59 | MP0009840_abnormal_foam_cell | 1.22458483 |
| 60 | MP0000604_amyloidosis | 1.19268958 |
| 61 | MP0003656_abnormal_erythrocyte_physiolo | 1.16355840 |
| 62 | MP0002933_joint_inflammation | 1.13691181 |
| 63 | MP0010307_abnormal_tumor_latency | 1.13064693 |
| 64 | MP0002332_abnormal_exercise_endurance | 1.11480066 |
| 65 | MP0009763_increased_sensitivity_to | 1.08848667 |
| 66 | MP0003763_abnormal_thymus_physiology | 1.07156444 |
| 67 | MP0004883_abnormal_blood_vessel | 1.05419746 |
| 68 | MP0003329_amyloid_beta_deposits | 1.00337139 |
| 69 | MP0000465_gastrointestinal_hemorrhage | 0.99368543 |
| 70 | MP0002396_abnormal_hematopoietic_system | 0.97436324 |
| 71 | MP0005164_abnormal_response_to | 0.97133452 |
| 72 | MP0003183_abnormal_peptide_metabolism | 0.95026906 |
| 73 | MP0005390_skeleton_phenotype | 0.94293037 |
| 74 | MP0001873_stomach_inflammation | 0.91219234 |
| 75 | MP0003045_fibrosis | 0.90842142 |
| 76 | MP0008260_abnormal_autophagy | 0.88900040 |
| 77 | MP0008004_abnormal_stomach_pH | 0.88831241 |
| 78 | MP0003195_calcinosis | 0.86708211 |
| 79 | MP0000015_abnormal_ear_pigmentation | 0.86269908 |
| 80 | MP0000249_abnormal_blood_vessel | 0.84810790 |
| 81 | MP0000703_abnormal_thymus_morphology | 0.84446603 |
| 82 | MP0004782_abnormal_surfactant_physiolog | 0.80028135 |
| 83 | MP0009765_abnormal_xenobiotic_induced | 0.78452651 |
| 84 | MP0003091_abnormal_cell_migration | 0.77954748 |
| 85 | MP0001545_abnormal_hematopoietic_system | 0.76260874 |
| 86 | MP0005397_hematopoietic_system_phenotyp | 0.76260874 |
| 87 | MP0002090_abnormal_vision | 0.75482955 |
| 88 | MP0005174_abnormal_tail_pigmentation | 0.75338615 |
| 89 | MP0003866_abnormal_defecation | 0.75318669 |
| 90 | MP0008873_increased_physiological_sensi | 0.74253873 |
| 91 | MP0001542_abnormal_bone_strength | 0.72810019 |
| 92 | MP0009278_abnormal_bone_marrow | 0.72663610 |
| 93 | MP0002877_abnormal_melanocyte_morpholog | 0.69720468 |
| 94 | MP0008874_decreased_physiological_sensi | 0.69045543 |
| 95 | MP0005647_abnormal_sex_gland | 0.68870681 |
| 96 | MP0000569_abnormal_digit_pigmentation | 0.66635634 |
| 97 | MP0000371_diluted_coat_color | 0.66534298 |
| 98 | MP0003795_abnormal_bone_structure | 0.64033095 |
| 99 | MP0003950_abnormal_plasma_membrane | 0.63692974 |
| 100 | MP0002132_abnormal_respiratory_system | 0.63675409 |
| 101 | MP0000490_abnormal_crypts_of | 0.62810027 |
| 102 | MP0002254_reproductive_system_inflammat | 0.59544876 |
| 103 | MP0002138_abnormal_hepatobiliary_system | 0.57843240 |
| 104 | MP0002136_abnormal_kidney_physiology | 0.56678044 |
| 105 | MP0001915_intracranial_hemorrhage | 0.55984821 |
| 106 | MP0003453_abnormal_keratinocyte_physiol | 0.54970333 |
| 107 | MP0000767_abnormal_smooth_muscle | 0.54431259 |
| 108 | MP0003566_abnormal_cell_adhesion | 0.53289440 |
| 109 | MP0000609_abnormal_liver_physiology | 0.52823561 |
| 110 | MP0005319_abnormal_enzyme/_coenzyme | 0.52422566 |
| 111 | MP0003646_muscle_fatigue | 0.50561224 |
| 112 | MP0002693_abnormal_pancreas_physiology | 0.49716670 |
| 113 | MP0005365_abnormal_bile_salt | 0.49360701 |
| 114 | MP0002928_abnormal_bile_duct | 0.48899047 |
| 115 | MP0005409_darkened_coat_color | 0.45145729 |
| 116 | MP0001663_abnormal_digestive_system | 0.45126890 |
| 117 | MP0003279_aneurysm | 0.44905861 |
| 118 | MP0008007_abnormal_cellular_replicative | 0.43748883 |
| 119 | MP0005257_abnormal_intraocular_pressure | 0.43015985 |
| 120 | MP0005165_increased_susceptibility_to | 0.42503128 |
| 121 | MP0004808_abnormal_hematopoietic_stem | 0.42108148 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 7.85963558 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.97378628 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.27335145 |
| 4 | Eczematoid dermatitis (HP:0000976) | 5.86837715 |
| 5 | Glomerulonephritis (HP:0000099) | 5.83054241 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.35171152 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.99735572 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 4.51604739 |
| 9 | Myositis (HP:0100614) | 4.32226081 |
| 10 | Abnormality of glycolipid metabolism (HP:0010969) | 4.31902240 |
| 11 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.31902240 |
| 12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.31902240 |
| 13 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.31270737 |
| 14 | Vacuolated lymphocytes (HP:0001922) | 4.28445873 |
| 15 | Loss of speech (HP:0002371) | 4.14754555 |
| 16 | Complement deficiency (HP:0004431) | 4.03633519 |
| 17 | Recurrent skin infections (HP:0001581) | 4.00270543 |
| 18 | Optic neuritis (HP:0100653) | 3.93123923 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 3.93123923 |
| 20 | Orchitis (HP:0100796) | 3.85748761 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 3.71060134 |
| 22 | Dysostosis multiplex (HP:0000943) | 3.65335238 |
| 23 | Obstructive lung disease (HP:0006536) | 3.65213742 |
| 24 | Chronic obstructive pulmonary disease (HP:0006510) | 3.65213742 |
| 25 | Abnormality of complement system (HP:0005339) | 3.50408291 |
| 26 | Recurrent fungal infections (HP:0002841) | 3.47995007 |
| 27 | Gingivitis (HP:0000230) | 3.33645494 |
| 28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.29587935 |
| 29 | Axonal loss (HP:0003447) | 3.26222322 |
| 30 | Thick nail (HP:0001805) | 3.25153509 |
| 31 | Disinhibition (HP:0000734) | 3.19985036 |
| 32 | Stomatitis (HP:0010280) | 3.18927259 |
| 33 | Nephritis (HP:0000123) | 3.18896443 |
| 34 | Neurofibrillary tangles (HP:0002185) | 3.18682929 |
| 35 | Arterial tortuosity (HP:0005116) | 3.14796616 |
| 36 | Meningitis (HP:0001287) | 3.07417345 |
| 37 | Recurrent cutaneous fungal infections (HP:0011370) | 2.97152924 |
| 38 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.97152924 |
| 39 | Pustule (HP:0200039) | 2.91638997 |
| 40 | Prostate neoplasm (HP:0100787) | 2.90015524 |
| 41 | Recurrent viral infections (HP:0004429) | 2.87613205 |
| 42 | Spontaneous hematomas (HP:0007420) | 2.82641490 |
| 43 | Hematochezia (HP:0002573) | 2.82377844 |
| 44 | Vasculitis (HP:0002633) | 2.78849672 |
| 45 | Chronic diarrhea (HP:0002028) | 2.78062650 |
| 46 | Encephalitis (HP:0002383) | 2.75664761 |
| 47 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.70497887 |
| 48 | Basal ganglia calcification (HP:0002135) | 2.69877218 |
| 49 | Vascular tortuosity (HP:0004948) | 2.69584720 |
| 50 | Mutism (HP:0002300) | 2.69265414 |
| 51 | Agnosia (HP:0010524) | 2.63899950 |
| 52 | Nuclear cataract (HP:0100018) | 2.63310083 |
| 53 | Mucopolysacchariduria (HP:0008155) | 2.56581595 |
| 54 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.56581595 |
| 55 | Purpura (HP:0000979) | 2.54836825 |
| 56 | Apathy (HP:0000741) | 2.53183247 |
| 57 | Hepatosplenomegaly (HP:0001433) | 2.52002580 |
| 58 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.51796498 |
| 59 | Gangrene (HP:0100758) | 2.51303345 |
| 60 | Periodontitis (HP:0000704) | 2.48872101 |
| 61 | Diminished motivation (HP:0000745) | 2.47599696 |
| 62 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.47225012 |
| 63 | Gastrointestinal infarctions (HP:0005244) | 2.47172306 |
| 64 | Neuronal loss in central nervous system (HP:0002529) | 2.47167374 |
| 65 | Leukocytosis (HP:0001974) | 2.44776442 |
| 66 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.43551893 |
| 67 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.43551893 |
| 68 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.43551893 |
| 69 | Colitis (HP:0002583) | 2.42883369 |
| 70 | Keratoconjunctivitis sicca (HP:0001097) | 2.42699633 |
| 71 | Pulmonary infiltrates (HP:0002113) | 2.41700502 |
| 72 | Eosinophilia (HP:0001880) | 2.40363046 |
| 73 | Amyloidosis (HP:0011034) | 2.39221785 |
| 74 | Inflammation of the large intestine (HP:0002037) | 2.38449919 |
| 75 | Polyneuropathy (HP:0001271) | 2.37242458 |
| 76 | Retinal atrophy (HP:0001105) | 2.36633898 |
| 77 | Progressive neurologic deterioration (HP:0002344) | 2.35226944 |
| 78 | Recurrent pneumonia (HP:0006532) | 2.35152071 |
| 79 | Arterial thrombosis (HP:0004420) | 2.34534699 |
| 80 | Hemoptysis (HP:0002105) | 2.31751538 |
| 81 | Increased CSF protein (HP:0002922) | 2.31676261 |
| 82 | Increased serum ferritin (HP:0003281) | 2.30333082 |
| 83 | Cerebral inclusion bodies (HP:0100314) | 2.30122483 |
| 84 | Prolonged bleeding time (HP:0003010) | 2.28614157 |
| 85 | Autoimmune thrombocytopenia (HP:0001973) | 2.27178284 |
| 86 | Progressive visual loss (HP:0000529) | 2.26266825 |
| 87 | Myocardial infarction (HP:0001658) | 2.24294038 |
| 88 | Cellulitis (HP:0100658) | 2.23298208 |
| 89 | Autoimmune hemolytic anemia (HP:0001890) | 2.21750604 |
| 90 | Hypoproteinemia (HP:0003075) | 2.20788783 |
| 91 | Keratoconjunctivitis (HP:0001096) | 2.20056026 |
| 92 | Upper motor neuron abnormality (HP:0002127) | 2.18932034 |
| 93 | Pulmonary embolism (HP:0002204) | 2.13750530 |
| 94 | Interstitial pulmonary disease (HP:0006530) | 2.11261598 |
| 95 | Cheilitis (HP:0100825) | 2.10342386 |
| 96 | Gastrointestinal inflammation (HP:0004386) | 2.08582914 |
| 97 | Hypergammaglobulinemia (HP:0010702) | 2.07885800 |
| 98 | Abnormality of eosinophils (HP:0001879) | 2.07406791 |
| 99 | Granulocytopenia (HP:0001913) | 2.07089156 |
| 100 | Osteomyelitis (HP:0002754) | 2.05899104 |
| 101 | Increased IgE level (HP:0003212) | 2.02304978 |
| 102 | IgM deficiency (HP:0002850) | 2.02208871 |
| 103 | Abnormality of the pleura (HP:0002103) | 2.02135809 |
| 104 | Anorexia (HP:0002039) | 2.01406789 |
| 105 | Metaphyseal irregularity (HP:0003025) | 2.01024619 |
| 106 | Urethral obstruction (HP:0000796) | 2.00728770 |
| 107 | Abnormality of iron homeostasis (HP:0011031) | 2.00253030 |
| 108 | Pathologic fracture (HP:0002756) | 1.99966486 |
| 109 | Chronic otitis media (HP:0000389) | 1.99447706 |
| 110 | Urticaria (HP:0001025) | 1.97513460 |
| 111 | Joint swelling (HP:0001386) | 1.97320650 |
| 112 | Personality changes (HP:0000751) | 1.97318597 |
| 113 | Joint hemorrhage (HP:0005261) | 1.97250392 |
| 114 | Malnutrition (HP:0004395) | 1.97126206 |
| 115 | Petechiae (HP:0000967) | 1.96192612 |
| 116 | Abnormality of the prostate (HP:0008775) | 1.96121234 |
| 117 | Gingival bleeding (HP:0000225) | 1.95070941 |
| 118 | Abnormality of T cell number (HP:0011839) | 1.94916355 |
| 119 | T lymphocytopenia (HP:0005403) | 1.94567561 |
| 120 | Increased IgM level (HP:0003496) | 1.93914606 |
| 121 | Memory impairment (HP:0002354) | 1.93331845 |
| 122 | Inappropriate behavior (HP:0000719) | 1.93104462 |
| 123 | Cerebral aneurysm (HP:0004944) | 1.93045393 |
| 124 | Global brain atrophy (HP:0002283) | 1.92235080 |
| 125 | Chest pain (HP:0100749) | 1.92200316 |
| 126 | Disproportionate tall stature (HP:0001519) | 1.91212924 |
| 127 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.90663037 |
| 128 | Glomerulopathy (HP:0100820) | 1.89100549 |
| 129 | Vertigo (HP:0002321) | 1.88949671 |
| 130 | Abnormality of T cells (HP:0002843) | 1.87238677 |
| 131 | Asymmetric septal hypertrophy (HP:0001670) | 1.87233708 |
| 132 | Premature loss of primary teeth (HP:0006323) | 1.85201064 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 5.11768591 |
| 2 | TXK | 4.17567636 |
| 3 | BLK | 3.75664566 |
| 4 | TYK2 | 3.57873232 |
| 5 | RIPK4 | 3.37528819 |
| 6 | IRAK4 | 3.35695822 |
| 7 | IRAK3 | 3.05352913 |
| 8 | MAP3K14 | 2.93205605 |
| 9 | JAK1 | 2.84092062 |
| 10 | NME2 | 2.50025555 |
| 11 | MAPK15 | 2.48484854 |
| 12 | DDR2 | 2.41763698 |
| 13 | MAP4K1 | 2.38032008 |
| 14 | TBK1 | 2.30874174 |
| 15 | CSF1R | 2.25925830 |
| 16 | TAOK2 | 2.23108604 |
| 17 | RIPK1 | 1.97151989 |
| 18 | ITK | 1.84931112 |
| 19 | IKBKE | 1.84109927 |
| 20 | MAP3K11 | 1.82337084 |
| 21 | KIT | 1.80913286 |
| 22 | TAOK1 | 1.80024634 |
| 23 | IKBKB | 1.78807172 |
| 24 | CSK | 1.74366983 |
| 25 | MAP3K3 | 1.67192903 |
| 26 | ZAP70 | 1.56402229 |
| 27 | JAK3 | 1.51822693 |
| 28 | CDC42BPA | 1.51398117 |
| 29 | HCK | 1.51001347 |
| 30 | LYN | 1.49760760 |
| 31 | PBK | 1.46262323 |
| 32 | EPHB1 | 1.45224533 |
| 33 | LCK | 1.43403703 |
| 34 | BMPR2 | 1.42492021 |
| 35 | FES | 1.40311614 |
| 36 | FGR | 1.38216180 |
| 37 | CAMK1D | 1.37759499 |
| 38 | ACVR1B | 1.37031641 |
| 39 | SYK | 1.35349173 |
| 40 | NEK9 | 1.34384133 |
| 41 | STK10 | 1.24877481 |
| 42 | MAP3K13 | 1.17318945 |
| 43 | CLK1 | 1.16780002 |
| 44 | BTK | 1.16245067 |
| 45 | TYRO3 | 1.13566560 |
| 46 | TEC | 1.13108087 |
| 47 | SIK2 | 1.08856283 |
| 48 | TAOK3 | 1.07966697 |
| 49 | MAP3K1 | 1.07022293 |
| 50 | JAK2 | 1.03960162 |
| 51 | CAMK1G | 1.00649874 |
| 52 | YES1 | 1.00463317 |
| 53 | * GRK7 | 0.96248631 |
| 54 | PIM2 | 0.93493571 |
| 55 | TESK2 | 0.89631687 |
| 56 | SIK3 | 0.89110677 |
| 57 | IRAK1 | 0.87427352 |
| 58 | PIM1 | 0.84010843 |
| 59 | MATK | 0.83917436 |
| 60 | MAP3K5 | 0.83437874 |
| 61 | MARK3 | 0.82453760 |
| 62 | TRPM7 | 0.80965996 |
| 63 | ABL2 | 0.76358669 |
| 64 | EIF2AK2 | 0.75855357 |
| 65 | MST4 | 0.75837087 |
| 66 | CHUK | 0.74354297 |
| 67 | ERN1 | 0.73447956 |
| 68 | FGFR3 | 0.71584774 |
| 69 | IGF1R | 0.66462887 |
| 70 | PRPF4B | 0.65580002 |
| 71 | MAPK7 | 0.64727771 |
| 72 | MOS | 0.63578742 |
| 73 | MAPKAPK2 | 0.63310102 |
| 74 | PRKCQ | 0.61955591 |
| 75 | MAP2K6 | 0.59923067 |
| 76 | IRAK2 | 0.58651772 |
| 77 | MAPK12 | 0.58370136 |
| 78 | DAPK2 | 0.58144571 |
| 79 | EPHA3 | 0.57494634 |
| 80 | TNK2 | 0.57257031 |
| 81 | VRK1 | 0.55810870 |
| 82 | PRKCD | 0.55186960 |
| 83 | EGFR | 0.53875600 |
| 84 | ABL1 | 0.52929564 |
| 85 | CDK3 | 0.52538048 |
| 86 | PLK2 | 0.51772118 |
| 87 | RPS6KA4 | 0.51458023 |
| 88 | CAMKK2 | 0.51105261 |
| 89 | MAPKAPK5 | 0.50461716 |
| 90 | CDK6 | 0.48751302 |
| 91 | PDPK1 | 0.47045749 |
| 92 | PIK3CG | 0.45250185 |
| 93 | GSK3A | 0.44533311 |
| 94 | GRK5 | 0.43333428 |
| 95 | FYN | 0.43232323 |
| 96 | TESK1 | 0.42589870 |
| 97 | PDGFRA | 0.41841603 |
| 98 | SGK3 | 0.41634033 |
| 99 | MAPK4 | 0.41300995 |
| 100 | RPS6KC1 | 0.41085229 |
| 101 | RPS6KL1 | 0.41085229 |
| 102 | PKN1 | 0.40668760 |
| 103 | PAK4 | 0.40395524 |
| 104 | NUAK1 | 0.39965598 |
| 105 | INSR | 0.39387246 |
| 106 | FGFR4 | 0.39124233 |
| 107 | BMPR1B | 0.38716363 |
| 108 | HIPK2 | 0.38518881 |
| 109 | ARAF | 0.36080099 |
| 110 | KSR2 | 0.35392855 |
| 111 | PDK1 | 0.33324914 |
| 112 | RPS6KA5 | 0.33277302 |
| 113 | NEK6 | 0.32669886 |
| 114 | RPS6KA6 | 0.32333846 |
| 115 | GRK6 | 0.32304336 |
| 116 | TSSK6 | 0.30815527 |
| 117 | DYRK3 | 0.30019968 |
| 118 | TTN | 0.29457759 |
| 119 | BMX | 0.29021801 |
| 120 | STK4 | 0.28848564 |
| 121 | DMPK | 0.27698213 |
| 122 | MARK2 | 0.27475619 |
| 123 | MAP2K3 | 0.26899839 |
| 124 | CDK4 | 0.23539516 |
| 125 | CAMK4 | 0.23053732 |
| 126 | RPS6KA2 | 0.22919118 |
| 127 | CASK | 0.22317208 |
| 128 | PRKCH | 0.20523609 |
| 129 | PDGFRB | 0.20399777 |
| 130 | PRKG1 | 0.19466123 |
| 131 | SRC | 0.18243799 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.21315279 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.10525496 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.27194296 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.86703157 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.56164586 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.54993798 |
| 7 | Pertussis_Homo sapiens_hsa05133 | 2.43325938 |
| 8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.32931386 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.31101761 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.31047812 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 2.28467824 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.23872941 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.13050579 |
| 14 | Lysosome_Homo sapiens_hsa04142 | 2.09670558 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.97845234 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 1.94318332 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.91698921 |
| 18 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.86719922 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.81373216 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.79429014 |
| 21 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.78556372 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.74455433 |
| 23 | Legionellosis_Homo sapiens_hsa05134 | 1.66704529 |
| 24 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.64199853 |
| 25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.58532617 |
| 26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.56703066 |
| 27 | Phagosome_Homo sapiens_hsa04145 | 1.54348689 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.45510291 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.43160074 |
| 30 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.41546504 |
| 31 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.37828373 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.37310081 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.36637444 |
| 34 | Salmonella infection_Homo sapiens_hsa05132 | 1.36285524 |
| 35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.30868595 |
| 36 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30091775 |
| 37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.28686389 |
| 38 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.25828806 |
| 39 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.24747226 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.21397683 |
| 41 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.19809046 |
| 42 | Viral myocarditis_Homo sapiens_hsa05416 | 1.18404339 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 1.16659219 |
| 44 | Prion diseases_Homo sapiens_hsa05020 | 1.14188546 |
| 45 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.12401331 |
| 46 | Asthma_Homo sapiens_hsa05310 | 1.08550537 |
| 47 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.03967265 |
| 48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.99006551 |
| 49 | Hepatitis B_Homo sapiens_hsa05161 | 0.97882635 |
| 50 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.97844879 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 0.94250474 |
| 52 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.91603786 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.91422902 |
| 54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74509300 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 0.73995056 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.73105057 |
| 57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71711224 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.70283665 |
| 59 | Bladder cancer_Homo sapiens_hsa05219 | 0.68561648 |
| 60 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.62729141 |
| 61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60226889 |
| 62 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.58716584 |
| 63 | Amoebiasis_Homo sapiens_hsa05146 | 0.57877101 |
| 64 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.57682694 |
| 65 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.57453073 |
| 66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.56819314 |
| 67 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.56190609 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.54334414 |
| 69 | * Endocytosis_Homo sapiens_hsa04144 | 0.53514884 |
| 70 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.50273923 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49792601 |
| 72 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.49453838 |
| 73 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.48066509 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47004653 |
| 75 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46099083 |
| 76 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44607235 |
| 77 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.44014756 |
| 78 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43416778 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42291364 |
| 80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40415016 |
| 81 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.37502969 |
| 82 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.36010467 |
| 83 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.35809547 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.34120273 |
| 85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.29094916 |
| 86 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28116640 |
| 87 | HTLV-I infection_Homo sapiens_hsa05166 | 0.27664361 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.26868047 |
| 89 | Colorectal cancer_Homo sapiens_hsa05210 | 0.25888579 |
| 90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24809659 |
| 91 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.24363986 |
| 92 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.24047912 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.23833903 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.22333979 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.21629906 |
| 96 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.21166990 |
| 97 | Mineral absorption_Homo sapiens_hsa04978 | 0.20754987 |
| 98 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.19397256 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.19235465 |
| 100 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.19021181 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.17882185 |
| 102 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.17711880 |
| 103 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.17675853 |
| 104 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.16438247 |
| 105 | Renin secretion_Homo sapiens_hsa04924 | 0.16366725 |
| 106 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.15547333 |
| 107 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.14793072 |
| 108 | Adherens junction_Homo sapiens_hsa04520 | 0.14791729 |
| 109 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.13694661 |
| 110 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.13625766 |
| 111 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.13336179 |
| 112 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.13260823 |
| 113 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.13009066 |
| 114 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.11761488 |
| 115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.11395698 |

